Mike Masters

Masters Capital Management LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Atlanta, Georgia. The firm was founded by Michael “Mike” Masters in 1994 and provides discretionary investment advisory services and management services to various pooled investment vehicles intended for sophisticated investors and institutional investors.

BioCircuit Technologies, Inc. develops non-invasive electrophysiology devices. It provides clinicians with simple-to-use devices that provide non-invasive access to nerve activity, enabling more precise diagnosis and individualized treatment. The company is headquartered in Atlanta, GA.

Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA.